Skip to content

Clinical trials

Recruiting Hematologic Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Status: Recruiting Country / region: Italy Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20171
20181
20191
20213
20221
20232
20242
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS Azienda Ospedaliero-Universitaria di Bologna4
Azienda USL Reggio Emilia - IRCCS2
Incyte Corporation2
Kura Oncology, Inc.2
Merck Sharp & Dohme LLC2
CSL Behring1
Cogent Biosciences, Inc.1
Curis, Inc.1
Daiichi Sankyo1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms22
Leukemia4
Lymphoma, Non-Hodgkin4
Leukemia, Myeloid, Acute3
Neoplasms3
Hematologic Diseases2
Immune System Diseases2
Leukemia, Myeloid2
Lymphoma, Large B-Cell, Diffuse2
Multiple Myeloma2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.